Health Data Research UK Phase 1 Investment


Closing Date: 5th October 2017

Health Data Research UK (HDR UK) has been established through an initial £50m partnership investment over the next five years led by the MRC, together with National Institute of Health Research (England), Chief Scientist Office (Scotland), Health and Care Research Wales, the Engineering and Physical Sciences Research Council (EPSRC), the Economic and Social Research Council (ESRC), the British Heart Foundation, and Wellcome. Harnessing the power of the NHS and associated health and biomedical data in the UK, HDR UK will develop and apply the cutting-edge informatics approaches needed to address the most pressing health research challenges facing patients and the public.

Following the announcement of Professor Andrew Morris FRSE FMedSci as the inaugural HDR UK Director in March this year, the funders, on behalf of HDR UK, are pleased to announce the launch of this competition to identify the initial Substantive Sites of the Institute.  These sites will provide the core capacity and capabilities needed to deliver the Institute’s mission and strategic vision.

This call expects to identify 5-7 Substantive Sites to address challenging research priorities identified by the HDR UK Director, which would be difficult to fund through traditional funding mechanisms. The Substantive Sites will be supported through long-term awards (10years+), with approximately £25m initially invested by HDR UK over this first five-year period.  An emphasis on working in partnership is strongly encouraged, with most Substantive Sites expected to comprise more than one RO.  HDR UK Sites will be expected to take a leadership role, not only across local partners, but more significantly across the UK to deliver the research priorities of the Institute at scale.

This is the first of several phases of investment to establish HDR UK, with competitions to follow including to establish the HDR UK Future Leaders Programme and to address strategic research challenges through investing in additional Partnership and/or Substantive Sites.

Further information is available on the MRC website